Sindhu Hospitals Launches Major Community Cancer Screening Drive to Champion Early Detection

Date:

Share post:

In a proactive effort to combat rising oncology rates, Sindhu Hospitals,a newly inaugurated, state-of-the-art, 1,500-bed comprehensive cancer care institution has announced the launch of a widespread community cancer screening initiative under its flagship campaign, “Early Detection Saves Lives.”

The dedicated campaign focuses on bridging the critical gap between symptom onset and formal diagnosis. By providing accessible, heavily subsidized, and advanced diagnostic screenings to the public, Sindhu Hospitals aims to detect malignancies at their earliest, most treatable stages. Specialized screenings will cover high-prevalence conditions including breast, cervical, oral, and colorectal cancers.

“Receiving a cancer diagnosis can be an incredibly overwhelming milestone, but early interception radically transforms survival outcomes,” stated the hospital’s medical advisory panel. “Through this initiative, we are mobilizing our world-class diagnostic capabilities directly into the community to catch abnormalities before they advance.”

Backed by the hospital’s expansive infrastructure including over 150 consultation rooms and cutting-edge laboratory facilities thecampaign will also feature educational workshops to dispel common myths surrounding oncology treatments. Public screening registrations are officially open at all Sindhu Hospitals facilities.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...